Literature DB >> 29195118

Deciphering p53 signaling in tumor suppression.

Stephano S Mello1, Laura D Attardi2.   

Abstract

The p53 transcription factor is mutated in over half of human cancers, and p53-null mice are highly predisposed to cancer, highlighting p53s essential role in tumor suppression. Studies in mouse models have revealed that p53 cell cycle arrest and apoptosis responses to acute DNA damage signals are dispensable for tumor suppression, prompting a search for new mechanisms underlying p53-mediated cancer suppression. p53 responds to other types of stress signals and regulates a host other cellular processes, including maintenance of genomic stability, metabolism, stemness, non-apoptotic cell death, migration/invasion, and cell signaling, any or all of which could be fundamental for suppressing carcinogenesis. The ability of p53 to govern numerous transcriptional programs and cellular functions likely explains its potent tumor suppressor activity.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29195118      PMCID: PMC5949255          DOI: 10.1016/j.ceb.2017.11.005

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  79 in total

Review 1.  Context is everything: extrinsic signalling and gain-of-function p53 mutants.

Authors:  Ivano Amelio; Gerry Melino
Journal:  Cell Death Discov       Date:  2020-03-23

2.  Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells.

Authors:  Emarndeena H Cheteh; Victoria Sarne; Sophia Ceder; Julie Bianchi; Martin Augsten; Helene Rundqvist; Lars Egevad; Arne Östman; Klas G Wiman
Journal:  Cell Death Discov       Date:  2020-06-02

3.  Protective effects of Brazilian propolis supplementation on capillary regression in the soleus muscle of hindlimb-unloaded rats.

Authors:  Masayuki Tanaka; Miho Kanazashi; Noriaki Maeshige; Hiroyo Kondo; Akihiko Ishihara; Hidemi Fujino
Journal:  J Physiol Sci       Date:  2018-09-19       Impact factor: 2.781

Review 4.  Transposons, p53 and Genome Security.

Authors:  Bhavana Tiwari; Amanda E Jones; John M Abrams
Journal:  Trends Genet       Date:  2018-09-05       Impact factor: 11.639

Review 5.  Advances in targeted therapy for malignant lymphoma.

Authors:  Li Wang; Wei Qin; Yu-Jia Huo; Xiao Li; Qing Shi; John E J Rasko; Anne Janin; Wei-Li Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-03-06

6.  Siva plays a critical role in mouse embryonic development.

Authors:  Suzanne B R Jacobs; Jeanine L Van Nostrand; Margot E Bowen; Julie C Baker; Laura D Attardi
Journal:  Cell Death Differ       Date:  2019-06-04       Impact factor: 15.828

7.  The Hippo Pathway Prevents YAP/TAZ-Driven Hypertranscription and Controls Neural Progenitor Number.

Authors:  Alfonso Lavado; Jun Young Park; Joshua Paré; David Finkelstein; Haitao Pan; Beisi Xu; Yiping Fan; Ram Parikshan Kumar; Geoffrey Neale; Young Don Kwak; Peter J McKinnon; Randy L Johnson; Xinwei Cao
Journal:  Dev Cell       Date:  2018-10-25       Impact factor: 12.270

Review 8.  Inflammatory and Fibrinolytic System in Acute Respiratory Distress Syndrome.

Authors:  Mahesh Manjunath Gouda; Sadiya B Shaikh; Yashodhar Prabhakar Bhandary
Journal:  Lung       Date:  2018-08-18       Impact factor: 2.584

Review 9.  Advances in targeted therapy for malignant lymphoma.

Authors:  Li Wang; Wei Qin; Yu-Jia Huo; Xiao Li; Qing Shi; John E J Rasko; Anne Janin; Wei-Li Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-03-06

10.  Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.

Authors:  Kathryn T Bieging-Rolett; Alyssa M Kaiser; David W Morgens; Anthony M Boutelle; Jose A Seoane; Eric L Van Nostrand; Changyu Zhu; Shauna L Houlihan; Stephano S Mello; Brian A Yee; Jacob McClendon; Sarah E Pierce; Ian P Winters; Mengxiong Wang; Andrew J Connolly; Scott W Lowe; Christina Curtis; Gene W Yeo; Monte M Winslow; Michael C Bassik; Laura D Attardi
Journal:  Mol Cell       Date:  2020-11-05       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.